SPY319.40+8.04 2.58%
DIA271.51+8.18 3.11%
IXIC9,814.08+198.27 2.06%

H.C. Wainwright Reiterates Buy on Aridis Pharmaceuticals, Raises Price Target to $11

H.C. Wainwright analyst Vernon Bernardino reiterates Aridis Pharmaceuticals (NASDAQ:ARDS) with a Buy and raises the price target from $7 to $11.

Benzinga · 05/15/2020 11:22

H.C. Wainwright analyst Vernon Bernardino reiterates Aridis Pharmaceuticals (NASDAQ:ARDS) with a Buy and raises the price target from $7 to $11.